Medite Cancer Diagnostics, Inc. of Orlando, FL, a company, filed a Form D exempt-offering notice with the SEC on 2014-04-16. The offering totals $2.5M, of which $1.5M was reported sold. Industry: Biotechnology.
Showing 25 of 37 people.
| Name | Role | Location |
|---|---|---|
| John Abeles | Director | Manassas, VA |
| Xavier F Carbonell | Director | CHICAGO, IL |
| Robert McCullough | Director | New York, NY |
| Alexander F Milley | Director | CHICAGO, IL |
| Augusto F Ocana | Director | CHICAGO, IL |
| Michael Ott | Director | Hopkins, MN |
| Mauro F Scimia | Director | CHICAGO, IL |
| Robert McCullough | Executive Officer | New York, NY |
| Michael Ott | Executive Officer | Hopkins, MN |
| John Austin Abeles, MD | Director | Orlando, FL |
| William Austin Lewis IV | Director | Orlando, FL |
| Joel Austin Kanter | Director | Orlando, FL |
| Stephen Von Rump | Director | Orlando, FL |
| Stephen Von Rump | Executive Officer | Orlando, FL |
| Stephen Von Rump | Promoter | Orlando, FL |
| Gary Pickett | Executive Officer | Orlando, FL |
| Gregory Austin Fortunoff | Director | Orlando, FL |
| Stephen Lawrence Von Rump | Director | Orlando, FL |
| Stephen Lawrence Von Rump | Executive Officer | Orlando, FL |
| Stephen Lawrence Von Rump | Promoter | Orlando, FL |
| John Eugene Abeles, MD | Director | Orlando, FL |
| Stephen Eugene Von Rump | Director | Orlando, FL |
| Stephen Eugene Von Rump | Executive Officer | Orlando, FL |
| Gregory Eugene Fortunoff | Director | Orlando, FL |
| Joel Eugene Kanter | Director | Orlando, FL |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2018-10-26 | D | $1.0M | $870K |
| 2018-07-12 | D | $1.0M | $850K |
| 2018-02-22 | D | $1.5M | $1.2M |
| 2017-10-16 | D | $6.9M | $5.9M |
| 2017-03-09 | D | $4.3M | $555K |
| 2017-02-09 | D | $3.0M | $412K |
| 2016-11-03 | D/A | $3.0M | $400K |
| 2016-11-02 | D | $3.0M | $400K |
| 2016-06-03 | D | $150K | $150K |
| 2016-01-11 | D | $500K | $500K |